APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ion Channel Modulators

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ion Channel Modulators Market Analysis and Forecast 2026-2032

21 December 2025203 pages

Choose your research edition.

Industry ResearchIon Channel Modulators Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Ion Channel Modulators Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Ion Channel Modulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ion Channel Modulators Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Ion Channel Modulators Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Ion Channel Modulators market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Ion Channel Modulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ion Channel Modulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ion Channel Modulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ion Channel Modulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Ion Channel Modulators include Sanofi (France), Pfizer, Inc. (US), GlaxoSmithKline Plc. (UK), AstraZeneca (UK), Zalicus, Inc. (US), Xention Limited (UK), Targacept, Inc. (US), Parion Sciences, Inc. (US) and Novartis AG (Switzerland), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Ion Channel Modulators, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ion Channel Modulators, also provides the revenue of main regions and countries. Of the upcoming market potential for Ion Channel Modulators, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ion Channel Modulators revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ion Channel Modulators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Ion Channel Modulators revenue, projected growth trends, production technology, application and end-user industry.

Ion Channel Modulators Segment by Company

Sanofi (France)

Pfizer, Inc. (US)

GlaxoSmithKline Plc. (UK)

AstraZeneca (UK)

Zalicus, Inc. (US)

Xention Limited (UK)

Targacept, Inc. (US)

Parion Sciences, Inc. (US)

Novartis AG (Switzerland)

Neusentis, Inc. (US)

NeuroSearch A/S (Denmark)

Nanion Technologies GmbH (Germany)

flyion GmbH (Germany)

Evotec AG (Germany)

Cytocentrics AG (Germany)

Convergence Pharmaceuticals Limited (UK)

Cellectricon AB (Sweden)

CalciMedica, Inc. (US)

Aurora Biomed, Inc. (Canada)

Ion Channel Modulators Segment by Type

Channel Blockers

Channel Openers

Ion Channel Modulators Segment by Application

Clinical Trials

Hospital

Other

Ion Channel Modulators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ion Channel Modulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ion Channel Modulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ion Channel Modulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Ion Channel Modulators in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Ion Channel Modulators company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ion Channel Modulators revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ion Channel Modulators Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Channel Blockers Major Player Table 3. Channel Openers Major Player Table 4. Global Ion Channel Modulators Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinical Trials Major Player Table 6. Hospital Major Player Table 7. Other Major Player Table 8. Ion Channel Modulators Industry Trends Table 9. Ion Channel Modulators Industry Drivers Table 10. Ion Channel Modulators Industry Opportunities and Challenges Table 11. Ion Channel Modulators Industry Restraints Table 12. Global Ion Channel Modulators Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Ion Channel Modulators Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Ion Channel Modulators Market Share by Region (2021-2026) Table 15. Global Ion Channel Modulators Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Ion Channel Modulators Market Share by Region (2027-2032) Table 17. Global Ion Channel Modulators Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Ion Channel Modulators Revenue Market Share by Players (2021-2026) Table 19. Global Ion Channel Modulators Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Ion Channel Modulators Key Players Headquarters & Area Served Table 21. Global Ion Channel Modulators Players, Product Type & Application Table 22. Global Ion Channel Modulators Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Ion Channel Modulators by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Ion Channel Modulators Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ion Channel Modulators Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Ion Channel Modulators Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Ion Channel Modulators Revenue Market Share by Type (2021-2026) Table 29. Global Ion Channel Modulators Revenue Market Share by Type (2027-2032) Table 30. Global Ion Channel Modulators Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Ion Channel Modulators Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Ion Channel Modulators Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Ion Channel Modulators Revenue Market Share by Application (2021-2026) Table 34. Global Ion Channel Modulators Revenue Market Share by Application (2027-2032) Table 35. Sanofi (France) Company Information Table 36. Sanofi (France) Business Overview Table 37. Sanofi (France) Ion Channel Modulators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sanofi (France) Ion Channel Modulators Product Portfolio Table 39. Sanofi (France) Recent Development Table 40. Pfizer, Inc. (US) Company Information Table 41. Pfizer, Inc. (US) Business Overview Table 42. Pfizer, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Pfizer, Inc. (US) Ion Channel Modulators Product Portfolio Table 44. Pfizer, Inc. (US) Recent Development Table 45. GlaxoSmithKline Plc. (UK) Company Information Table 46. GlaxoSmithKline Plc. (UK) Business Overview Table 47. GlaxoSmithKline Plc. (UK) Ion Channel Modulators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. GlaxoSmithKline Plc. (UK) Ion Channel Modulators Product Portfolio Table 49. GlaxoSmithKline Plc. (UK) Recent Development Table 50. AstraZeneca (UK) Company Information Table 51. AstraZeneca (UK) Business Overview Table 52. AstraZeneca (UK) Ion Channel Modulators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. AstraZeneca (UK) Ion Channel Modulators Product Portfolio Table 54. AstraZeneca (UK) Recent Development Table 55. Zalicus, Inc. (US) Company Information Table 56. Zalicus, Inc. (US) Business Overview Table 57. Zalicus, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Zalicus, Inc. (US) Ion Channel Modulators Product Portfolio Table 59. Zalicus, Inc. (US) Recent Development Table 60. Xention Limited (UK) Company Information Table 61. Xention Limited (UK) Business Overview Table 62. Xention Limited (UK) Ion Channel Modulators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Xention Limited (UK) Ion Channel Modulators Product Portfolio Table 64. Xention Limited (UK) Recent Development Table 65. Targacept, Inc. (US) Company Information Table 66. Targacept, Inc. (US) Business Overview Table 67. Targacept, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Targacept, Inc. (US) Ion Channel Modulators Product Portfolio Table 69. Targacept, Inc. (US) Recent Development Table 70. Parion Sciences, Inc. (US) Company Information Table 71. Parion Sciences, Inc. (US) Business Overview Table 72. Parion Sciences, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Parion Sciences, Inc. (US) Ion Channel Modulators Product Portfolio Table 74. Parion Sciences, Inc. (US) Recent Development Table 75. Novartis AG (Switzerland) Company Information Table 76. Novartis AG (Switzerland) Business Overview Table 77. Novartis AG (Switzerland) Ion Channel Modulators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Novartis AG (Switzerland) Ion Channel Modulators Product Portfolio Table 79. Novartis AG (Switzerland) Recent Development Table 80. Neusentis, Inc. (US) Company Information Table 81. Neusentis, Inc. (US) Business Overview Table 82. Neusentis, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Neusentis, Inc. (US) Ion Channel Modulators Product Portfolio Table 84. Neusentis, Inc. (US) Recent Development Table 85. NeuroSearch A/S (Denmark) Company Information Table 86. NeuroSearch A/S (Denmark) Business Overview Table 87. NeuroSearch A/S (Denmark) Ion Channel Modulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. NeuroSearch A/S (Denmark) Ion Channel Modulators Product Portfolio Table 89. NeuroSearch A/S (Denmark) Recent Development Table 90. Nanion Technologies GmbH (Germany) Company Information Table 91. Nanion Technologies GmbH (Germany) Business Overview Table 92. Nanion Technologies GmbH (Germany) Ion Channel Modulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Nanion Technologies GmbH (Germany) Ion Channel Modulators Product Portfolio Table 94. Nanion Technologies GmbH (Germany) Recent Development Table 95. flyion GmbH (Germany) Company Information Table 96. flyion GmbH (Germany) Business Overview Table 97. flyion GmbH (Germany) Ion Channel Modulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. flyion GmbH (Germany) Ion Channel Modulators Product Portfolio Table 99. flyion GmbH (Germany) Recent Development Table 100. Evotec AG (Germany) Company Information Table 101. Evotec AG (Germany) Business Overview Table 102. Evotec AG (Germany) Ion Channel Modulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Evotec AG (Germany) Ion Channel Modulators Product Portfolio Table 104. Evotec AG (Germany) Recent Development Table 105. Cytocentrics AG (Germany) Company Information Table 106. Cytocentrics AG (Germany) Business Overview Table 107. Cytocentrics AG (Germany) Ion Channel Modulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Cytocentrics AG (Germany) Ion Channel Modulators Product Portfolio Table 109. Cytocentrics AG (Germany) Recent Development Table 110. Convergence Pharmaceuticals Limited (UK) Company Information Table 111. Convergence Pharmaceuticals Limited (UK) Business Overview Table 112. Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Product Portfolio Table 114. Convergence Pharmaceuticals Limited (UK) Recent Development Table 115. Cellectricon AB (Sweden) Company Information Table 116. Cellectricon AB (Sweden) Business Overview Table 117. Cellectricon AB (Sweden) Ion Channel Modulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Cellectricon AB (Sweden) Ion Channel Modulators Product Portfolio Table 119. Cellectricon AB (Sweden) Recent Development Table 120. CalciMedica, Inc. (US) Company Information Table 121. CalciMedica, Inc. (US) Business Overview Table 122. CalciMedica, Inc. (US) Ion Channel Modulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. CalciMedica, Inc. (US) Ion Channel Modulators Product Portfolio Table 124. CalciMedica, Inc. (US) Recent Development Table 125. Aurora Biomed, Inc. (Canada) Company Information Table 126. Aurora Biomed, Inc. (Canada) Business Overview Table 127. Aurora Biomed, Inc. (Canada) Ion Channel Modulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Aurora Biomed, Inc. (Canada) Ion Channel Modulators Product Portfolio Table 129. Aurora Biomed, Inc. (Canada) Recent Development Table 130. North America Ion Channel Modulators Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Ion Channel Modulators Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Ion Channel Modulators Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Ion Channel Modulators Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Ion Channel Modulators Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Ion Channel Modulators Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Ion Channel Modulators Revenue by Country (US$ Million) & (2027-2032) Table 137. Europe Ion Channel Modulators Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Ion Channel Modulators Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Ion Channel Modulators Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Ion Channel Modulators Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Ion Channel Modulators Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Ion Channel Modulators Revenue by Country (2021-2026) & (US$ Million) Table 143. Europe Ion Channel Modulators Revenue by Country (US$ Million) & (2027-2032) Table 144. China Ion Channel Modulators Revenue by Type (2021-2026) & (US$ Million) Table 145. China Ion Channel Modulators Revenue by Type (2027-2032) & (US$ Million) Table 146. China Ion Channel Modulators Revenue by Application (2021-2026) & (US$ Million) Table 147. China Ion Channel Modulators Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Ion Channel Modulators Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Ion Channel Modulators Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Ion Channel Modulators Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Ion Channel Modulators Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Ion Channel Modulators Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Ion Channel Modulators Revenue by Region (US$ Million) & (2021-2026) Table 154. Asia Ion Channel Modulators Revenue by Region (US$ Million) & (2027-2032) Table 155. SAMEA Ion Channel Modulators Revenue by Type (2021-2026) & (US$ Million) Table 156. SAMEA Ion Channel Modulators Revenue by Type (2027-2032) & (US$ Million) Table 157. SAMEA Ion Channel Modulators Revenue by Application (2021-2026) & (US$ Million) Table 158. SAMEA Ion Channel Modulators Revenue by Application (2027-2032) & (US$ Million) Table 159. SAMEA Ion Channel Modulators Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. SAMEA Ion Channel Modulators Revenue by Country (2021-2026) & (US$ Million) Table 161. SAMEA Ion Channel Modulators Revenue by Country (US$ Million) & (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Ion Channel Modulators Image Figure 2. Global Ion Channel Modulators Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ion Channel Modulators Market Size Share 2021 VS 2025 VS 2032 Figure 4. Channel Blockers Image Figure 5. Channel Openers Image Figure 6. Global Ion Channel Modulators Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ion Channel Modulators Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinical Trials Image Figure 9. Hospital Image Figure 10. Other Image Figure 11. Global Ion Channel Modulators Market Size (US$ Million) & (2021-2032) Figure 12. Global Ion Channel Modulators Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Ion Channel Modulators Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Ion Channel Modulators Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Ion Channel Modulators Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Ion Channel Modulators Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Ion Channel Modulators Revenue Market Share by Type (2021-2032) Figure 19. Global Ion Channel Modulators Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Ion Channel Modulators Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Ion Channel Modulators Revenue Market Share by Application (2021-2032) Figure 22. North America Ion Channel Modulators Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Ion Channel Modulators Revenue Share by Type (2021-2032) Figure 24. North America Ion Channel Modulators Revenue Share by Application (2021-2032) Figure 25. North America Ion Channel Modulators Revenue Share by Country (2021-2032) Figure 26. United States Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Ion Channel Modulators Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Ion Channel Modulators Revenue Share by Type (2021-2032) Figure 31. Europe Ion Channel Modulators Revenue Share by Application (2021-2032) Figure 32. Europe Ion Channel Modulators Revenue Share by Country (2021-2032) Figure 33. Germany Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Ion Channel Modulators Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Ion Channel Modulators Revenue Share by Type (2021-2032) Figure 43. China Ion Channel Modulators Revenue Share by Application (2021-2032) Figure 44. Asia Ion Channel Modulators Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Ion Channel Modulators Revenue Share by Type (2021-2032) Figure 46. Asia Ion Channel Modulators Revenue Share by Application (2021-2032) Figure 47. Asia Ion Channel Modulators Revenue Share by Region (2021-2032) Figure 48. Japan Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Ion Channel Modulators Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Ion Channel Modulators Revenue Share by Type (2021-2032) Figure 56. SAMEA Ion Channel Modulators Revenue Share by Application (2021-2032) Figure 57. SAMEA Ion Channel Modulators Revenue Share by Country (2021-2032) Figure 58. Brazil Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Ion Channel Modulators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Channel Blockers
  • Channel Openers
Applications
  • Clinical Trials
  • Hospital
  • Other
Companies covered
  • Sanofi (France)
  • Pfizer, Inc. (US)
  • GlaxoSmithKline Plc. (UK)
  • AstraZeneca (UK)
  • Zalicus, Inc. (US)
  • Xention Limited (UK)
  • Targacept, Inc. (US)
  • Parion Sciences, Inc. (US)
  • Novartis AG (Switzerland)
  • Neusentis, Inc. (US)
  • NeuroSearch A/S (Denmark)
  • Nanion Technologies GmbH (Germany)
  • flyion GmbH (Germany)
  • Evotec AG (Germany)
  • Cytocentrics AG (Germany)
  • Convergence Pharmaceuticals Limited (UK)
  • Cellectricon AB (Sweden)
  • CalciMedica, Inc. (US)
  • Aurora Biomed, Inc. (Canada)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ion Channel Modulators Market by Type
  3. 1.2.1 Global Ion Channel Modulators Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Channel Blockers
  5. 1.2.3 Channel Openers
  6. 1.3 Ion Channel Modulators Market by Application
  7. 1.3.1 Global Ion Channel Modulators Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinical Trials
  9. 1.3.3 Hospital
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Ion Channel Modulators Market Dynamics
  1. 2.1 Ion Channel Modulators Industry Trends
  2. 2.2 Ion Channel Modulators Industry Drivers
  3. 2.3 Ion Channel Modulators Industry Opportunities and Challenges
  4. 2.4 Ion Channel Modulators Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Ion Channel Modulators Market Perspective (2021-2032)
  2. 3.2 Global Ion Channel Modulators Growth Trends by Region
  3. 3.2.1 Global Ion Channel Modulators Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ion Channel Modulators Market Size by Region (2021-2026)
  5. 3.2.3 Global Ion Channel Modulators Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Ion Channel Modulators Revenue by Players
  2. 4.1.1 Global Ion Channel Modulators Revenue by Players (2021-2026)
  3. 4.1.2 Global Ion Channel Modulators Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Ion Channel Modulators Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ion Channel Modulators Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Ion Channel Modulators Key Players Headquarters & Area Served
  7. 4.4 Global Ion Channel Modulators Players, Product Type & Application
  8. 4.5 Global Ion Channel Modulators Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Ion Channel Modulators Market CR5 and HHI
  11. 4.6.3 2025 Ion Channel Modulators Tier 1, Tier 2, and Tier 3
5 Ion Channel Modulators Market Size by Type
  1. 5.1 Global Ion Channel Modulators Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Ion Channel Modulators Revenue by Type (2021-2032)
  3. 5.3 Global Ion Channel Modulators Revenue Market Share by Type (2021-2032)
6 Ion Channel Modulators Market Size by Application
  1. 6.1 Global Ion Channel Modulators Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Ion Channel Modulators Revenue by Application (2021-2032)
  3. 6.3 Global Ion Channel Modulators Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sanofi (France)
  2. 7.1.1 Sanofi (France) Company Information
  3. 7.1.2 Sanofi (France) Business Overview
  4. 7.1.3 Sanofi (France) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi (France) Ion Channel Modulators Product Portfolio
  6. 7.1.5 Sanofi (France) Recent Developments
  7. 7.2 Pfizer, Inc. (US)
  8. 7.2.1 Pfizer, Inc. (US) Company Information
  9. 7.2.2 Pfizer, Inc. (US) Business Overview
  10. 7.2.3 Pfizer, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer, Inc. (US) Ion Channel Modulators Product Portfolio
  12. 7.2.5 Pfizer, Inc. (US) Recent Developments
  13. 7.3 GlaxoSmithKline Plc. (UK)
  14. 7.3.1 GlaxoSmithKline Plc. (UK) Company Information
  15. 7.3.2 GlaxoSmithKline Plc. (UK) Business Overview
  16. 7.3.3 GlaxoSmithKline Plc. (UK) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline Plc. (UK) Ion Channel Modulators Product Portfolio
  18. 7.3.5 GlaxoSmithKline Plc. (UK) Recent Developments
  19. 7.4 AstraZeneca (UK)
  20. 7.4.1 AstraZeneca (UK) Company Information
  21. 7.4.2 AstraZeneca (UK) Business Overview
  22. 7.4.3 AstraZeneca (UK) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca (UK) Ion Channel Modulators Product Portfolio
  24. 7.4.5 AstraZeneca (UK) Recent Developments
  25. 7.5 Zalicus, Inc. (US)
  26. 7.5.1 Zalicus, Inc. (US) Company Information
  27. 7.5.2 Zalicus, Inc. (US) Business Overview
  28. 7.5.3 Zalicus, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Zalicus, Inc. (US) Ion Channel Modulators Product Portfolio
  30. 7.5.5 Zalicus, Inc. (US) Recent Developments
  31. 7.6 Xention Limited (UK)
  32. 7.6.1 Xention Limited (UK) Company Information
  33. 7.6.2 Xention Limited (UK) Business Overview
  34. 7.6.3 Xention Limited (UK) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Xention Limited (UK) Ion Channel Modulators Product Portfolio
  36. 7.6.5 Xention Limited (UK) Recent Developments
  37. 7.7 Targacept, Inc. (US)
  38. 7.7.1 Targacept, Inc. (US) Company Information
  39. 7.7.2 Targacept, Inc. (US) Business Overview
  40. 7.7.3 Targacept, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Targacept, Inc. (US) Ion Channel Modulators Product Portfolio
  42. 7.7.5 Targacept, Inc. (US) Recent Developments
  43. 7.8 Parion Sciences, Inc. (US)
  44. 7.8.1 Parion Sciences, Inc. (US) Company Information
  45. 7.8.2 Parion Sciences, Inc. (US) Business Overview
  46. 7.8.3 Parion Sciences, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Parion Sciences, Inc. (US) Ion Channel Modulators Product Portfolio
  48. 7.8.5 Parion Sciences, Inc. (US) Recent Developments
  49. 7.9 Novartis AG (Switzerland)
  50. 7.9.1 Novartis AG (Switzerland) Company Information
  51. 7.9.2 Novartis AG (Switzerland) Business Overview
  52. 7.9.3 Novartis AG (Switzerland) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Novartis AG (Switzerland) Ion Channel Modulators Product Portfolio
  54. 7.9.5 Novartis AG (Switzerland) Recent Developments
  55. 7.10 Neusentis, Inc. (US)
  56. 7.10.1 Neusentis, Inc. (US) Company Information
  57. 7.10.2 Neusentis, Inc. (US) Business Overview
  58. 7.10.3 Neusentis, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Neusentis, Inc. (US) Ion Channel Modulators Product Portfolio
  60. 7.10.5 Neusentis, Inc. (US) Recent Developments
  61. 7.11 NeuroSearch A/S (Denmark)
  62. 7.11.1 NeuroSearch A/S (Denmark) Company Information
  63. 7.11.2 NeuroSearch A/S (Denmark) Business Overview
  64. 7.11.3 NeuroSearch A/S (Denmark) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  65. 7.11.4 NeuroSearch A/S (Denmark) Ion Channel Modulators Product Portfolio
  66. 7.11.5 NeuroSearch A/S (Denmark) Recent Developments
  67. 7.12 Nanion Technologies GmbH (Germany)
  68. 7.12.1 Nanion Technologies GmbH (Germany) Company Information
  69. 7.12.2 Nanion Technologies GmbH (Germany) Business Overview
  70. 7.12.3 Nanion Technologies GmbH (Germany) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Nanion Technologies GmbH (Germany) Ion Channel Modulators Product Portfolio
  72. 7.12.5 Nanion Technologies GmbH (Germany) Recent Developments
  73. 7.13 flyion GmbH (Germany)
  74. 7.13.1 flyion GmbH (Germany) Company Information
  75. 7.13.2 flyion GmbH (Germany) Business Overview
  76. 7.13.3 flyion GmbH (Germany) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  77. 7.13.4 flyion GmbH (Germany) Ion Channel Modulators Product Portfolio
  78. 7.13.5 flyion GmbH (Germany) Recent Developments
  79. 7.14 Evotec AG (Germany)
  80. 7.14.1 Evotec AG (Germany) Company Information
  81. 7.14.2 Evotec AG (Germany) Business Overview
  82. 7.14.3 Evotec AG (Germany) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Evotec AG (Germany) Ion Channel Modulators Product Portfolio
  84. 7.14.5 Evotec AG (Germany) Recent Developments
  85. 7.15 Cytocentrics AG (Germany)
  86. 7.15.1 Cytocentrics AG (Germany) Company Information
  87. 7.15.2 Cytocentrics AG (Germany) Business Overview
  88. 7.15.3 Cytocentrics AG (Germany) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Cytocentrics AG (Germany) Ion Channel Modulators Product Portfolio
  90. 7.15.5 Cytocentrics AG (Germany) Recent Developments
  91. 7.16 Convergence Pharmaceuticals Limited (UK)
  92. 7.16.1 Convergence Pharmaceuticals Limited (UK) Company Information
  93. 7.16.2 Convergence Pharmaceuticals Limited (UK) Business Overview
  94. 7.16.3 Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Product Portfolio
  96. 7.16.5 Convergence Pharmaceuticals Limited (UK) Recent Developments
  97. 7.17 Cellectricon AB (Sweden)
  98. 7.17.1 Cellectricon AB (Sweden) Company Information
  99. 7.17.2 Cellectricon AB (Sweden) Business Overview
  100. 7.17.3 Cellectricon AB (Sweden) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Cellectricon AB (Sweden) Ion Channel Modulators Product Portfolio
  102. 7.17.5 Cellectricon AB (Sweden) Recent Developments
  103. 7.18 CalciMedica, Inc. (US)
  104. 7.18.1 CalciMedica, Inc. (US) Company Information
  105. 7.18.2 CalciMedica, Inc. (US) Business Overview
  106. 7.18.3 CalciMedica, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  107. 7.18.4 CalciMedica, Inc. (US) Ion Channel Modulators Product Portfolio
  108. 7.18.5 CalciMedica, Inc. (US) Recent Developments
  109. 7.19 Aurora Biomed, Inc. (Canada)
  110. 7.19.1 Aurora Biomed, Inc. (Canada) Company Information
  111. 7.19.2 Aurora Biomed, Inc. (Canada) Business Overview
  112. 7.19.3 Aurora Biomed, Inc. (Canada) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Aurora Biomed, Inc. (Canada) Ion Channel Modulators Product Portfolio
  114. 7.19.5 Aurora Biomed, Inc. (Canada) Recent Developments
8 North America
  1. 8.1 North America Ion Channel Modulators Revenue (2021-2032)
  2. 8.2 North America Ion Channel Modulators Revenue by Type (2021-2032)
  3. 8.2.1 North America Ion Channel Modulators Revenue by Type (2021-2026)
  4. 8.2.2 North America Ion Channel Modulators Revenue by Type (2027-2032)
  5. 8.3 North America Ion Channel Modulators Revenue Share by Type (2021-2032)
  6. 8.4 North America Ion Channel Modulators Revenue by Application (2021-2032)
  7. 8.4.1 North America Ion Channel Modulators Revenue by Application (2021-2026)
  8. 8.4.2 North America Ion Channel Modulators Revenue by Application (2027-2032)
  9. 8.5 North America Ion Channel Modulators Revenue Share by Application (2021-2032)
  10. 8.6 North America Ion Channel Modulators Revenue by Country
  11. 8.6.1 North America Ion Channel Modulators Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Ion Channel Modulators Revenue by Country (2021-2026)
  13. 8.6.3 North America Ion Channel Modulators Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Ion Channel Modulators Revenue (2021-2032)
  2. 9.2 Europe Ion Channel Modulators Revenue by Type (2021-2032)
  3. 9.2.1 Europe Ion Channel Modulators Revenue by Type (2021-2026)
  4. 9.2.2 Europe Ion Channel Modulators Revenue by Type (2027-2032)
  5. 9.3 Europe Ion Channel Modulators Revenue Share by Type (2021-2032)
  6. 9.4 Europe Ion Channel Modulators Revenue by Application (2021-2032)
  7. 9.4.1 Europe Ion Channel Modulators Revenue by Application (2021-2026)
  8. 9.4.2 Europe Ion Channel Modulators Revenue by Application (2027-2032)
  9. 9.5 Europe Ion Channel Modulators Revenue Share by Application (2021-2032)
  10. 9.6 Europe Ion Channel Modulators Revenue by Country
  11. 9.6.1 Europe Ion Channel Modulators Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Ion Channel Modulators Revenue by Country (2021-2026)
  13. 9.6.3 Europe Ion Channel Modulators Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Ion Channel Modulators Revenue (2021-2032)
  2. 10.2 China Ion Channel Modulators Revenue by Type (2021-2032)
  3. 10.2.1 China Ion Channel Modulators Revenue by Type (2021-2026)
  4. 10.2.2 China Ion Channel Modulators Revenue by Type (2027-2032)
  5. 10.3 China Ion Channel Modulators Revenue Share by Type (2021-2032)
  6. 10.4 China Ion Channel Modulators Revenue by Application (2021-2032)
  7. 10.4.1 China Ion Channel Modulators Revenue by Application (2021-2026)
  8. 10.4.2 China Ion Channel Modulators Revenue by Application (2027-2032)
  9. 10.5 China Ion Channel Modulators Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ion Channel Modulators Revenue (2021-2032)
  2. 11.2 Asia Ion Channel Modulators Revenue by Type (2021-2032)
  3. 11.2.1 Asia Ion Channel Modulators Revenue by Type (2021-2026)
  4. 11.2.2 Asia Ion Channel Modulators Revenue by Type (2027-2032)
  5. 11.3 Asia Ion Channel Modulators Revenue Share by Type (2021-2032)
  6. 11.4 Asia Ion Channel Modulators Revenue by Application (2021-2032)
  7. 11.4.1 Asia Ion Channel Modulators Revenue by Application (2021-2026)
  8. 11.4.2 Asia Ion Channel Modulators Revenue by Application (2027-2032)
  9. 11.5 Asia Ion Channel Modulators Revenue Share by Application (2021-2032)
  10. 11.6 Asia Ion Channel Modulators Revenue by Country
  11. 11.6.1 Asia Ion Channel Modulators Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Ion Channel Modulators Revenue by Country (2021-2026)
  13. 11.6.3 Asia Ion Channel Modulators Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ion Channel Modulators Revenue (2021-2032)
  2. 12.2 SAMEA Ion Channel Modulators Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Ion Channel Modulators Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Ion Channel Modulators Revenue by Type (2027-2032)
  5. 12.3 SAMEA Ion Channel Modulators Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Ion Channel Modulators Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Ion Channel Modulators Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Ion Channel Modulators Revenue by Application (2027-2032)
  9. 12.5 SAMEA Ion Channel Modulators Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Ion Channel Modulators Revenue by Country
  11. 12.6.1 SAMEA Ion Channel Modulators Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Ion Channel Modulators Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Ion Channel Modulators Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst